Randomized trial comparing aminoglutethimide with high-dose medroxyprogesterone acetate in therapy for advanced breast carcinoma.

Canney, P A; Priestman, T J; Griffiths, T; Latief, T N; Mould, J J; Spooner, D

Canney, P A; Priestman, T J; Griffiths, T; Latief, T N; Mould, J J; Spooner, D.

Affiliation

Canney PA; Wessex Regional Radiotherapy Centre, Royal South Hants Hospital, Southampton, England.

J Natl Cancer Inst ; 80(14): 1147-51, 1988 Sep 21.

Article in En | MEDLINE | ID: mdl-2970555

Subject(s)

Aminoglutethimide/therapeutic use; Breast Neoplasms/drug therapy; Medroxyprogesterone/analogs & derivatives; Aminoglutethimide/adverse effects; Breast Neoplasms/mortality; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone/adverse effects; Medroxyprogesterone/therapeutic use; Medroxyprogesterone Acetate; Middle Aged; Random Allocation; Tamoxifen/therapeutic use; Time Factors

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Aminoglutethimide / Medroxyprogesterone Type of study: Clinical_trials Limits: Female / Humans / Middle aged Language: En Journal: J Natl Cancer Inst Year: 1988 Type: Article Affiliation country: United kingdom

Search on Google

XML

PubMed Links